More News! For those who want to keep up with everything

Latest Posts

More News! 13 Sep 2022

Research charity calls on scientists, engineers, and technology experts to transform dialysis treatment

Following its successful MedTech competition earlier this year, the UK’s largest kidney research charity, Kidney Research UK, has launched a new competition aimed at innovations in dialysis that will have a significant impact on patients’ lives. In collaboration with IN-PART’s Discover platform, this year’s competition will encourage scientists, academics, engineers and technology experts to propose […]

September 13, 2022 - 3 minutesmins - By External Contributor

More News! 7 Sep 2022

Powerful, organic turmeric produced by controlled fermentation process

A controlled fermentation process has been used to produce an organic turmeric – a natural herb known for its health benefits and organoleptic properties. German pharmaceutical company, Cellavent, has recently entered the fermented botanical space with product, fermentlife Turmeric. Cellavent says its product is a powerful new organic turmeric that can offer a wide range […]

September 7, 2022 - 2 minutesmins - By Liza Laws

covid-19 vaccine emergency use authorization

More News! 24 Aug 2022

COVID-19 vaccine less sensitive to mutations being developed in Sweden

A new generation of coronavirus vaccine is being developed by Swedish researchers from the Karolinska Institutet. The vaccine is being specifically designed to be less sensitive to mutations and better equipped for any future strains. Promising results The vaccine showed promising results in mice in a newly published study in EMBO Molecular Medicine, and the researchers […]

August 24, 2022 - 3 minutesmins - By Liza Laws

PAN-TB collaboration: a new project for tuberculosis treatment

More News! 18 Aug 2022

Collaboration to advance investigational tuberculosis drug treatments

A collaboration called The Project to Accelerate New Treatments for Tuberculosis (PAN-TB) was announced yesterday (August 17). The joint development agreement (JDA) will support the progression of two investigational tuberculosis (TB) combination treatment regimens into phase 2 clinical development. The collaboration is made up of organizations contributing five antimicrobial agents. Active pulmonary TB Together they […]

August 18, 2022 - 5 minutesmins - By Liza Laws

More News! 12 Aug 2022

Planet’s plastic problem can be eased by enzyme engineering platform, researchers say

Steps have been taken to tackle the planet’s plastic problem by researchers from the Manchester Institute of Biotechnology (MIB). They have developed a new enzyme engineering platform to improve plastic degrading enzymes through directed evolution. The platform can successfully degrade polyethylene terephthalate (PET), the plastic commonly used in plastic bottles. Enzymatic recycling The researchers say […]

August 12, 2022 - 4 minutesmins - By Liza Laws

car-t therapy, combination therapy, car-t cell therapy, cancer therapy, blood cancer

More News! 3 Aug 2022

Allarity Therapeutics takes advice from its board and switches focus to combination therapies

US-based Allarity Therapeutics has made a decision to change tack and focus on combination therapy approaches while making the most of its current assets. The company says the new strategy, driven by its board of directors, aligns with the ongoing shift in oncology standard-of-care moving away from monotherapies. Instead it will veer towards more promising […]

August 3, 2022 - 3 minutesmins - By Liza Laws

More News! 3 Aug 2022

Orca Bio announces Precision-T phase 3 study open and enrolling patients across US transplant centers

US-based Orca Bio, today announced Precision-T, its pivotal phase 3 study, is open, enrolling and treating 174 leukemia patients at more than 20 clinical trial sites. Precision-T is a randomized, open-label multi-center study that is evaluating the safety and efficacy of Orca Bio’s lead investigational high-precision cell therapy, Orca-T, compared to standard of care allogeneic […]

August 3, 2022 - 2 minutesmins - By Liza Laws

More News! 29 Jul 2022

Cancer patients enrolled on study to predict immunotherapy response

An observational study has started enrolling patients with advanced/metastatic non-small cell lung cancer (NSCLC). Florida-based Nilogen Oncosystems made the announcement today (July 29) that those who are receiving immune checkpoint inhibitors in the standard of care will be registered for the study. Using advanced artificial intelligence and machine learning algorithms to discover biomarker signatures as […]

July 29, 2022 - 3 minutesmins - By Liza Laws

More News! 19 Jul 2022

Bayer Consumer Health launches microbiome research call to find new academic partners

Campaign launch date: Monday, July 18, 2022. Bayer Consumer Health has launched a call through IN-PART’s Discover platform to find and partner with academic experts and research groups working on microbiome-targeting solutions for upper respiratory illnesses, nutrition and digestive health as well as topical delivery through the skin. The campaign aims to accelerate Bayer’s “Partnering […]

July 19, 2022 - 3 minutesmins - By External Contributor

More News! 18 Jul 2022

Purespring Therapeutics and SwanBio Therapeutics announce agreement for use of FunSel screening platform

A licensing agreement for use of the FunSel screening platform has been announced by Purespring Therapeutics and SwanBio. Under the terms of the agreement, SwanBio will license the FunSel screening platform from Purespring to explore new targets for early-stage pipeline programs. SwanBio will have the option to develop any targets identified and to own and […]

July 18, 2022 - 2 minutesmins - By Liza Laws

More News! 13 Jul 2022

Paradigm of treatment of mental health to be transformed by gut-brain development program

Building on a decade of research, a development program for next-generation probiotics and therapeutics to modulate gut microbiota and mental health has been launched. Seed Health, a microbiome science company along with Axial Therapeutics, a clinical stage biopharmaceutical company announced the joint program in the US today (July 13). It will build on the work […]

July 13, 2022 - 3 minutesmins - By Liza Laws

More News! 8 Jul 2022

Beyond Biotech podcast 4: CorePath, Rensselaer, Versameb

This week’s guests are: Helen Zha, assistant professor of chemical and biological engineering and a member of the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute; Versameb CEO Klaas Zuideveld; and Aamir Ehsan, CEO and medical director of CorePath and Celina Villa, medical director of Biopharma Division. Versameb gives presentation during World […]

July 8, 2022 - 6 minutesmins - By Jim Cornall

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us